rs712
Variant in the KRAS gene (KRAS Proto-Oncogene, GTPase)
rs712 is a single nucleotide polymorphism (SNP) in the KRAS gene, involved in RAS-MAPK signaling. Variants at this position have been studied in relation to immune function, metabolism, and chronic illness.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is the rs712 variant?
rs712 is a SNP (single nucleotide polymorphism) in the KRAS (KRAS Proto-Oncogene, GTPase) gene. It belongs to the Signaling category and is part of the Cellular Signaling biological cluster. KRAS encodes a small GTPase that transduces growth factor receptor signals to activate ERK/MAPK pathways.
Biological role and pathway
This variant sits within the KRAS gene, which is involved in the RAS-MAPK signaling pathway. Genes within the Cellular Signaling cluster work together to maintain balanced function across interconnected biological systems.
Variants in genes within this pathway may influence an individual's predisposition to altered function — particularly under conditions of physiological stress such as viral infection or prolonged illness.
rs712 and Long COVID / ME-CFS research
KRAS-MAPK signaling influences inflammatory gene expression and immune cell proliferation; variants may modulate inflammatory responsiveness in Long COVID.
This information is based on published research and does not constitute medical advice. See references below.
Parent gene: KRAS
rs712 is one of 1 known variant in the KRAS gene. To understand the full biological context of this variant, explore the parent gene page.
View KRAS gene page →Conditions studied in relation to rs712
Research into KRAS variants including rs712 has explored associations with the following conditions. These are areas of scientific investigation and do not imply causation.
Genetic insights from DNA data
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may include KRAS and the rs712 variant.
The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. Results are presented in plain English with appropriate scientific context, no medical jargon, no scare tactics. All results should be discussed with a qualified healthcare provider.
Frequently asked questions
What is the rs712 variant in the KRAS gene?
rs712 is a single nucleotide polymorphism (SNP) located in the KRAS (KRAS Proto-Oncogene, GTPase) gene, which is involved in RAS-MAPK signaling. KRAS encodes a small GTPase that transduces growth factor receptor signals to activate ERK/MAPK pathways.
How may the rs712 variant relate to Long COVID or ME/CFS?
KRAS-MAPK signaling influences inflammatory gene expression and immune cell proliferation; variants may modulate inflammatory responsiveness in Long COVID.
Can a consumer DNA test detect the rs712 variant?
Many consumer DNA tests such as 23andMe, AncestryDNA, and MyHeritage genotype common SNPs. ChronicDNA analyses your raw DNA file and reports on variants studied in relation to chronic illness, immune function, and metabolism. This is not a diagnostic service — results are informational and educational only.
Find out if you carry the rs712 variant
Upload your DNA data from 23andMe, AncestryDNA, or MyHeritage and receive a personalised report covering >80 genes relevant to Long COVID and ME/CFS.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
References
The following publications were used in compiling the research context for KRAS and its variants. This is not an exhaustive literature review.
- [1]PMID: 34316049
- [2]Nature Genetics
- [3]Journal of Clinical Investigation